BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sudoł S, Kucwaj-Brysz K, Kurczab R, Wilczyńska N, Jastrzębska-Więsek M, Satała G, Latacz G, Głuch-Lutwin M, Mordyl B, Żesławska E, Nitek W, Partyka A, Buzun K, Doroz-Płonka A, Wesołowska A, Bielawska A, Handzlik J. Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo. Eur J Med Chem 2020;203:112529. [PMID: 32693296 DOI: 10.1016/j.ejmech.2020.112529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sudoł S, Cios A, Jastrzębska-Więsek M, Honkisz-Orzechowska E, Mordyl B, Wilczyńska-Zawal N, Satała G, Kucwaj-Brysz K, Partyka A, Latacz G, Olejarz-Maciej A, Wesołowska A, Handzlik J. The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases. Int J Mol Sci 2021;22:10773. [PMID: 34639113 DOI: 10.3390/ijms221910773] [Reference Citation Analysis]
2 Kucwaj-brysz K, Ali W, Kurczab R, Sudoł S, Wilczyńska-zawal N, Jastrzębska-więsek M, Satała G, Mordyl B, Żesławska E, Agnieszka-olejarz-maciej, Czarnota K, Latacz G, Partyka A, Wesołowska A, Nitek W, Handzlik J. An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105695] [Reference Citation Analysis]
3 Penjišević JZ, Šukalović VB, Andrić DB, Suručić R, Kostić-Rajačić SV. The Therapeutic Potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study. Appl Biochem Biotechnol 2022. [PMID: 35507251 DOI: 10.1007/s12010-022-03922-8] [Reference Citation Analysis]
4 Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J. Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2021;49:128275. [PMID: 34311086 DOI: 10.1016/j.bmcl.2021.128275] [Reference Citation Analysis]
5 Drop M, Canale V, Chaumont-Dubel S, Kurczab R, Satała G, Bantreil X, Walczak M, Koczurkiewicz-Adamczyk P, Latacz G, Gwizdak A, Krawczyk M, Gołębiowska J, Grychowska K, Bojarski AJ, Nikiforuk A, Subra G, Martinez J, Pawłowski M, Popik P, Marin P, Lamaty F, Zajdel P. 2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity. ACS Chem Neurosci 2021;12:1228-40. [PMID: 33705101 DOI: 10.1021/acschemneuro.1c00061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]